The advent of gene editing technologies, such as CRISPR-Cas9, has opened new avenues in toxicology. By modifying genes responsible for metabolizing toxins, scientists can potentially reduce the susceptibility of individuals to specific poisons. This approach holds promise for personalized medicine in toxicology, where treatments are tailored to the genetic makeup of individuals, improving efficacy and safety.
